The dengue fever outbreak in Thailand continues to affect seventy-seven provinces and has now been confirmed in 31,708 cases.
This national disease surveillance (File # 506) published by the Thailand Bureau of Epidemiology reflects a 24% increase in just four weeks.
Dengue viruses unfurl when chunks of mosquitoes from "Aedes aegypti" are transmitted to the human body. Dengue is not contagious now, and it is not passed from one person to another.
The incidence of dengue has increased dramatically, with 40 percent of the arena's residents now threatened with dengue, says the CDC.
The Thai Ministry of Health has launched various dengue prevention tactics, but the administration of the Dengvaxia vaccine is out of the field.
Thailand is investigating the effectiveness of Dengvaxia.
Here is the strategy of the World Health Organization (WHO) Advisory Crew of Experts (SAGE) on immunization confirming that the Dengvaxia vaccine needs to be managed in a more efficient and demanding manner.
In April 201
To prepare US voters for a visit to Thailand, the United States Department of Disease Administration and Prevention (CDC) updated their instructions for vaccinations prior to travel to Thailand sometime in March 2018.
** Agenda for Vax's Vaccination -Sooner-Thump **
Nonetheless, since September 1, 2018, the CDC has not now issued a Dengue-Coupled Slump Alert for Thailand.
And, the CDC says there are no opposite antiviral agents for dengue.
Dengue sufferers need to be instructed to get well hydrated and definitely to carry aspirin (acetylsalicylic acid), aspirin-containing medicines, and other non-steroidal anti-inflammatory drugs such as ibuprofen because of their anticoagulant properties, says the CDC.
Slump vaccines and medicines are available at certified pharmacies in the US.